December 16, 2019

In This Issue
Walmart Will Delay Electronic Prescribing Mandate
U.S. CDC: At Least 1,300 Deaths from Flu This Season...So Far
Schmidt Institute Opioid Program Expands Statewide
Opioid Related Webinars Offer CME Credit
This Week's Public Health Updates from the AMA
Resources From The Alzheimer's Association
MMA Legislative Calls Will Begin Tuesday, January 14th
Maine Legislature's List of Bill Titles for 2020 Session: Initial Approval List
Upcoming Specialty Society Meetings
MMA partners with the Maine Suicide Prevention Program and the Maine CDC/Sweetser to offer training for clinicians.
10th Annual Maine Patient Safety Academy - March 30, 2020
Orthopedic Surgeon Opportunity in Beautiful New England
Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
Family Medicine Physician
Family Medicine Opportunity in Beautiful Western Maine
BC/BE Family Medicine or Internal Medicine Physician
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health - Portland, ME

Search Back Issues



Follow Us:

Walmart Will Delay Electronic Prescribing Mandate

[from the American Medical Association]

Walmart had previously announced that it would require electronic prescribing for controlled substances (EPCS) for all controlled substances as of January 1, 2020, with no exceptions. The AMA and multiple medical societies opposed the mandate, urging a delay due to the likelihood for patient harm and how the Walmart policy did not comport with state or federal law.

We are pleased to report that Walmart said it will delay its EPCS mandate.

"We recognize not all provider networks and prescribers will have the technology and systems in place to accommodate this requirement, so we will continue to take written prescriptions so patients are not unintentionally negatively affected by this process," Walmart spokeswoman Marilee McInnis said in a statement to USA TODAY.

AMA President Patrice A. Harris, MD, MA, provided the following statement to USA Today:

“The AMA welcomes Walmart’s decision to delay implementation of an electronic prescribing mandate that would have resulted in harm to millions of Americans, including many in rural areas who rely on Walmart as the only pharmacy in reasonable distance. The policy, which the AMA urged Walmart to delay, was not developed in consultation with the nation’s physicians, who support electronic prescribing of controlled substances, but want to see it implemented in a manner that supports—rather than disrupts—patient care.”

"The AMA will continue to work with physicians, pharmacists, and other partners in health care to improve medication adherence, including removing barriers that impede physicians from electronically prescribing controlled substances."

The AMA will continue to monitor this development, and it encourages the help of all physicians in sharing this information with state medical and pharmacy boards, as appropriate, to ensure all pharmacies and other stakeholders comply with state law governing the prescribing and dispensing of controlled substances. Maine law requires opioids to be prescribed electronically, unless the prescriber has received a waiver from the Maine Prescription Drug Monitoring Program or fits into one of the few exceptions to the requirement.


Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©